Clinical Trial Update: Optimizing IFN Beta - 1B Dose [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating optimized dosing of interferon beta-1B for multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon beta-1B (Betaseron) (interferon beta-1B)

Snippet

Sponsor: University of Turin, Italy | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED